106 related articles for article (PubMed ID: 7631139)
21. Fragment E derived from both fibrin and fibrinogen stimulates interleukin-6 production in rat peritoneal macrophages.
Lee ME; Rhee KJ; Nham SU
Mol Cells; 1999 Feb; 9(1):7-13. PubMed ID: 10102564
[TBL] [Abstract][Full Text] [Related]
22. Separation of fibrinogen degradation products (FDP) by means of adsorption to insolubilized fibrinmonomer (FM-ag).
Heene DL; Matthias FR; Wegrzynowicz Z; Hocke G
Thromb Haemost; 1979 Jun; 41(4):677-86. PubMed ID: 483241
[TBL] [Abstract][Full Text] [Related]
23. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
Buczko W; De Blasi A
Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
[TBL] [Abstract][Full Text] [Related]
24. High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma.
Lee DH; Lee BK; Noh SM; Cho YS
Eur J Trauma Emerg Surg; 2018 Apr; 44(2):291-298. PubMed ID: 28921171
[TBL] [Abstract][Full Text] [Related]
25. Unreliability of current serum fibrin degradation product (FDP) assays.
Gaffney PJ; Perry MJ
Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
[TBL] [Abstract][Full Text] [Related]
26. [Persistent discrepancy between FDP and D-dimer in a patient with acute leukemia].
Sato N; Takahashi H; Nikuni K; Seki Y; Wada K; Tatewaki W; Shibata A
Rinsho Ketsueki; 1995 Mar; 36(3):212-7. PubMed ID: 7783324
[TBL] [Abstract][Full Text] [Related]
27. [Effect of matrix composition on chemotaxis response of monocytes stimulated by monocyte chemoattractant protein-1].
Kukhtina NB; Aref'eva TI; Aref'eva AM; Krasnikova TL
Ross Fiziol Zh Im I M Sechenova; 2003 Dec; 89(12):1577-81. PubMed ID: 14870496
[TBL] [Abstract][Full Text] [Related]
28. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro.
Morohoshi M; Fujisawa K; Uchimura I; Numano F
Diabetes; 1996 Jul; 45(7):954-9. PubMed ID: 8666148
[TBL] [Abstract][Full Text] [Related]
29. Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway.
Ritchie DG; Levy BA; Adams MA; Fuller GM
Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1530-4. PubMed ID: 6461860
[TBL] [Abstract][Full Text] [Related]
30. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
Dyr JE; Cajthamlová H; Suttnar J
Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
[TBL] [Abstract][Full Text] [Related]
31. Prediction of extravasation in pelvic fracture using coagulation biomarkers.
Aoki M; Hagiwara S; Tokue H; Shibuya K; Kaneko M; Murata M; Nakajima J; Sawada Y; Isshiki Y; Ichikawa Y; Oshima K
Injury; 2016 Aug; 47(8):1702-6. PubMed ID: 27267962
[TBL] [Abstract][Full Text] [Related]
32. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
[TBL] [Abstract][Full Text] [Related]
33. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
[TBL] [Abstract][Full Text] [Related]
34. Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP.
Freedman JE; Fabian A; Loscalzo J
Am J Physiol; 1995 Feb; 268(2 Pt 1):C520-6. PubMed ID: 7532361
[TBL] [Abstract][Full Text] [Related]
35. Increased fibrin/fibrinogen degradation products without increase of plasmin-alpha 2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma.
Takeda S; Katoh H; Takaki A; Okamoto K; Ohsato K
Thromb Res; 1990 Jan; 57(2):289-300. PubMed ID: 2156347
[TBL] [Abstract][Full Text] [Related]
36. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
Chen JP; Williams TK; Legendre AM
Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
[TBL] [Abstract][Full Text] [Related]
37. Fibrinogen synthesis in rabbits: effects of altered levels of circulating fibrinogen.
Alving BM; Bell WR; Evatt BL
Am J Physiol; 1977 May; 232(5):H478-84. PubMed ID: 860765
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
[TBL] [Abstract][Full Text] [Related]
39. [The role of Mac-1 and ICAM-1 molecules in adhesion of cells on fibronogen and its degradation products].
Aref'eva TI; Baĭdun LV; Aref'eva AM; Krasnikova TL
Tsitologiia; 2001; 43(12):1162-7. PubMed ID: 11881155
[TBL] [Abstract][Full Text] [Related]
40. False-negative test for fibrinogen--fibrin degradation products.
Kickler T; Bell WR
Am J Clin Pathol; 1977 Jul; 68(1):78-80. PubMed ID: 868807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
